| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.4M | — | -1.3% |
| Cost of Revenue | $1.9M | — | +54.1% |
| Gross Profit | $3.6M | — | -16.8% |
| R&D Expense | $1.2M | — | -3.3% |
| SG&A Expense | $1.8M | — | -24.1% |
| Operating Income | -$139K | — | +67.4% |
| Interest Expense | $355K | — | +9.6% |
| Pre-tax Income | -$494K | — | +34.2% |
| Net Income | -$494K | — | +34.2% |
| EPS (Basic) | -$0.01 | — | +50.0% |
| EPS (Diluted) | -$0.01 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.3M | -13.3% | +18.2% |
| Accounts Receivable | $1.7M | -13.0% | -21.2% |
| Current Assets | $3.9M | -7.0% | -3.7% |
| Total Assets | $4.3M | -7.5% | -37.7% |
| Current Liabilities | $17.1M | +121.2% | +181.6% |
| Long-term Debt | $9.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$229K | — | -166.3% |
| Capital Expenditures | $6K | — | +0.0% |
| Investing Cash Flow | -$6K | — | +0.0% |
| Free Cash Flow | -$235K | — | -155.4% |
| +12.0% |
| Total Liabilities | $17.2M | +0.4% | -0.2% |
| Stockholders' Equity | -$12.9M | -3.4% | -24.6% |